HALO logo
halo search icon
INmune Bio, Inc.

US$1.41

Price Change Indicator
0.00 (0.00%)
INmune Bio, Inc.
INMB · NAS

INmune Bio, Inc.

Start Trading INMB for Free

US$1.41

0.00 (0.00%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Earnings MomentumHALO GrowthHammer BullishHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

INmune Bio, Inc. Overview

INMB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About INMB

icon
icon

Telephone

1.858.964.3720

icon

Address

Suite 640, 225 NE Mizner Boulevard, Boca Raton, FL 33432

Description

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.

INMB Price Chart

Key Stats

Market Cap

US$37.49M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.09 - 11.64

Trade Value (12mth)

US$957,649.00

1 week

-9.03%

1 month

2.92%

YTD

-8.44%

1 year

-81.1%

All time high

30.37

Key Fundamentals

EPS 3 yr Growth

21.80%

EBITDA Margin

NaN%

Operating Cashflow

-$23m

Free Cash Flow Return

-80.30%

ROIC

-163.20%

Interest Coverage

0.00

Quick Ratio

3.60

Other Data

Shares Outstanding (Fully Diluted)

27m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

INMB Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
08 May 26
08 May 26
08 May 26

INMB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.67-2.11-1.86locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.67-2.11-1.86locklocklock
Growth
 %locklocklocklock-9.6-26.412.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of INmune Bio, Inc. (INMB:NAS)?
Halo FAQ
The current share price of INmune Bio, Inc. (INMB:NAS) is USD$1.41.
What is the 52-week high share price for INmune Bio, Inc. (INMB:NAS)?
Halo FAQ
The 52-week high share price for INmune Bio, Inc. (INMB:NAS) is USD$11.64.
What is the 52-week low share price for INmune Bio, Inc. (INMB:NAS)?
Halo FAQ
The 52-week low share price for INmune Bio, Inc. (INMB:NAS) is USD$1.09.
What is the dividend yield for INmune Bio, Inc. (INMB:NAS)?
Halo FAQ
INmune Bio, Inc. (INMB:NAS) does not pay a dividend.
What was INmune Bio, Inc. (INMB:NAS) last dividend payment?
Halo FAQ
INmune Bio, Inc. (INMB:NAS) does not pay a dividend.
What is the franking level for INmune Bio, Inc. (INMB:NAS)?
Halo FAQ
INmune Bio, Inc. (INMB:NAS) has a franking level of 0.00%.
In which sector is INmune Bio, Inc. (INMB:NAS) classified?
Halo FAQ
INmune Bio, Inc. (INMB:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial